Author:
Kaufmann M.,von Minckwitz G.,Bear H.D.,Buzdar A.,McGale P.,Bonnefoi H.,Colleoni M.,Denkert C.,Eiermann W.,Jackesz R.,Makris A.,Miller W.,Pierga J.-Y.,Semiglazov V.,Schneeweiss A.,Souchon R.,Stearns V.,Untch M.,Loibl S.
Reference72 articles.
1. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: an update;Kaufmann;J Clin Oncol,2006
2. Individualized treatment strategies according to in vivo chemosensitivity assessed by response after 2 cycles of neoadjuvant chemotherapy. Final results of the Gepartrio study of German Breast Group;von Minckwitz;Breast Cancer Res Treat,2006
3. Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer;Wenzel;Anticancer Drugs,2005
4. Primary chemotherapy with gemcitabine, liposomal doxorubicin, docetaxel in patients with locally advanced breast cancer: results of a phase I trial;Schmid;Anticancer Drugs,2005
5. Neoadjuvant therapy with gemcitabine in breast cancer;Schneeweiss;Oncology,2004